Cell Therapy – What Does It Take To Become a Mainstream Option
While cell therapies are still a small segment of therapeutics, the landscape is rapidly changing — with over 1,000 ongoing clinical trials and...
Blog
Read on
On Demand Webinar: Establishing a Stage-Gate Approach to Biomanufacturing
The need for advanced technology platforms that offer a clear, end-to-end path to commercial manufacturing is driving biotech companies to outsource...
Resilience Announces Equity Investment from Mubadala and Funding of New Biopharma Manufacturing Facility in the United Arab Emirates
SAN DIEGO--(BUSINESS WIRE)-- National Resilience, Inc. (Resilience), a technology-focused manufacturing company dedicated to broadening access to...
Future-Proof Your Aseptic Filling: A Joint Webinar by Resilience and Cytiva
Resilience is excited to participate in a joint webinar with Cytiva on how the use of SA25 Aseptic Filling Workcells at Resilience's Alachua, FL site...
Resilience Presenting at Precision Medicine World Conference
Resilience is proud to be participating in Precision Medicine World Conference, the largest annual conference dedicated to precision medicine. Our...
.png)
Resilience to Establish Biomanufacturing Partnership with AstraZeneca and Purchase Manufacturing Site
SAN DIEGO--National Resilience, Inc. (Resilience) and AstraZeneca PLC announced today that the companies will establish a long-term biomanufacturing...
Resilience Presenting at Advanced Therapies Week
Resilience is proud to be participating in Advanced Therapies Week. Join Eytan Abraham on as he hosts a panel featuring Carlos Candino from Be...
Cell Therapy – What Does It Take To Become a Mainstream Option
While cell therapies are still a small segment of therapeutics, the landscape is rapidly changing — with over 1,000 ongoing clinical trials and...